In short
Skin Anarchy Podcast Episode Summary
Podcast Title: Skin Anarchy Episode Title: A Breakthrough in Exosome Skincare ft. Madhavi Gavini of Droplette Host: Dr. Ekta Yadav Guest: Madhavi Gavini, Founder of Droplette
---
Episode Overview In this episode of Skin Anarchy, Dr. Ekta Yadav welcomes back Madhavi Gavini, founder of Droplette, a pioneering brand in the field of skincare technology. They discuss the evolution of skincare towards biologics, regenerative ingredients, and the crucial role of delivery science. The conversation focuses on Droplette's innovative exosome delivery system and its implications for skincare and medical treatments.
---
Key Concepts and Discussions
Origins of Droplette Technology
- Background of Madhavi Gavini:
- Former pharmaceutical developer focused on therapies for pediatric diseases.
- Encountered challenges in drug delivery, particularly for skin conditions.
- Foundation of Droplette:
- Developed to tackle the delivery issue of large molecules (e.g., genes, collagen, exosomes) into the skin without needles or injury.
- Utilizes high-velocity, submicron droplets to penetrate the stratum corneum.
Exosome Science Explained
- Definition of Exosomes:
- Extracellular vesicles secreted by both healthy and sick cells.
- Serve as messengers, containing DNA, RNA, and proteins.
- Relevance in Regenerative Skincare:
- Exosomes from healthy cells can promote regeneration, while those from sick cells may lead to deterioration of healthy cells.
- Current research focuses on their potential in treating skin conditions and injuries.
- Sourcing and Stability:
- Critical to ensure exosomes are sourced from healthy, viable cells (e.g., mesenchymal stem cells).
- Stability is a concern; exosomes degrade quickly if not stored properly (ideally frozen).
Delivery Mechanism
- Importance of Delivery in Skincare:
- Many topical treatments fail to penetrate the skin barrier effectively.
- Droplette's technology enhances delivery, enabling significant absorption and efficacy of active ingredients.
- Comparison with Traditional Methods:
- Traditional injection methods (e.g., microneedling) allow for deeper penetration, but Droplette provides a painless alternative.
Professional vs. Consumer Products
- Droplette Professional Line:
- Used by dermatologists, often after procedures like microneedling or laser treatments to aid in recovery.
- Consumer Product:
- Available as a starter set with an exosome serum for daily use, designed to be easily integrated into skincare routines.
Challenges and Misconceptions
- Misunderstanding of Exosomes:
- Distinction between stem cells and exosomes often confused; stem cells are cells capable of differentiation, while exosomes are signaling molecules derived from them.
- Misleading marketing and lack of regulation in the skincare industry regarding the efficacy and sourcing of exosome products.
- Consumer Awareness:
- Importance for consumers to inquire about product sourcing and delivery methods to ensure efficacy.
---
Key Takeaways
- Innovative Technology in Skincare: Droplette's technology offers a revolutionary approach to delivering large molecules into the skin effectively and painlessly.
- Exosome Potential: Understanding exosomes can reshape skincare, but sourcing and stability are critical for efficacy.
- Consumer Empowerment: Consumers should be informed and proactive about the products they use, especially in the rapidly evolving field of regenerative skincare.
Discount Code
- Use discount code 'ANARCHY' for a special offer on the Exosome Starter Set.
---
Conclusion This episode highlights the transformative potential of exosome technology in skincare, the importance of effective delivery mechanisms, and the need for consumer education in navigating the complexities of modern skincare products. Madhavi Gavini's insights showcase the intersection of science and beauty, paving the way for future innovations in the industry.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOThe Journey of Droplet
0:45 to 1:46
Madhavi shares the origins and evolution of Droplet in skincare technology.
“But just to like preface, like, when you first told me about Droplet, I was like blown away.”
Understanding Exosome Technology
1:46 to 3:36
Madhavi explains the science behind exosomes and their delivery to the skin.
“that codes for a connective protein that connects your skin to the tissue below it.”
Exosomes vs. Stem Cells
3:36 to 6:34
Discussion on the differences between stem cells and exosomes and their therapeutic potential.
“And so I love that droplets origins are from that like very, very heavy science, because I think that's what this industry needs more of.”
The Importance of Sourcing Exosomes
6:34 to 9:20
Madhavi emphasizes the significance of sourcing quality exosomes for skincare.
“But I think there's a huge misunderstanding also that's taking place where people are now saying stem cells and exosomes in the same sentence, and they're confusing the two.”
Mesenchymal Stem Cells and Their Benefits
9:20 to 12:18
Exploration of the role of mesenchymal stem cells in producing effective exosomes.
“of the cells and the type of cells that you're administering.”
Challenges in Exosome Applications
12:18 to 14:00
Discussion on the challenges faced in utilizing exosomes effectively in skincare products.
“We recently, you know, this is not quite yet published, but will be soon.”
Understanding Exosomes in Skincare
14:00 to 17:36
Learn about the fragility of exosomes and their impact on skincare efficacy.
“anything i mean it's like it's like a climbing a mountain you know so that is absolutely phenomenal I'm so excited for you.”
Challenges of Exosome Delivery
17:36 to 21:44
Explore the challenges of delivering exosomes effectively through the skin.
“I mean, just to give people a little framework.”
Professional vs. At-Home Exosome Treatments
21:44 to 24:19
Discover the differences between professional treatments and at-home exosome products.
“If you could tell us more about that versus the one that's going out to consumers.”
The Future of Exosomes in Dermatology
24:19 to 28:01
Discuss the regulatory landscape and future potential of exosomes in skincare.
“And I feel like Droplet just, like, I don't know.”
Show all 16 chapters
Exploring Exosomes: Insights and Experiences
28:01 to 29:20
Learn about the historical use and sourcing challenges of exosomes in skincare.
“And then when I met with them and I talked to Madhavi, she showed me all the research and it's kind of amazing.”
The Role of Consumers in Regenerative Medicine
29:21 to 30:48
Discover how consumer involvement is changing the landscape of regenerative medicine.
“Yeah, I mean, I feel like this is a whole new category in itself.”
Navigating Skincare Claims and Regulations
30:49 to 32:40
Understand the complexities of skincare claims and the lack of regulation.
“You know, I get so many devices sent to me and I hear and I have so many people talking to me about their products, either like their skincare products or their devices.”
Post-Procedure Care with Exosomes
32:41 to 33:36
Learn how exosome treatments can enhance post-procedure recovery.
“But then if you do get just normal microneedling, how do you feel that the droplet device fits into that kind of post-procedure recovery?”
Understanding the Droplet Device and Capsules
33:37 to 36:28
Explore how the Droplet device and capsules work for effective skincare delivery.
“You know, I want to dive into the actual product, though.”
The Importance of Ingredients Penetration in Skincare
36:29 to 39:02
Discover why ingredient penetration is crucial for effective skincare treatments.
“So yeah, so that's kind of how the system, how the kit is set up.”
Transcript
Automatic transcript. May contain errors.0:00Dr. Ekta Yadav:Hey guys, welcome back to Skin Anarchy. This is a very, very special episode. I'm welcoming back a very dear friend of mine, also someone I truly admire for her work in the scientific space, in the skin health space. She is truly a genius, and this brand is very special to me because they were one of our first big science-forward brands that we hosted on Skin Anarchy. So to welcome them back is truly like a full-circle moment for me. So without further ado, please welcome back the founder of Droplet, Madhavi. Welcome, Madhavi. I'm so excited to host you again.
0:30Madhavi Gavini:Thank you. I'm so excited to be here. I'm really excited to chat about what we've been building and so good to see you again, Ekta.
0:35Dr. Ekta Yadav:Yeah, no, it's so good. And I'm just so excited about what you're continuing to do in the space. I mean, I know when we first spoke about Droplet, and I'm going to have you like walk our listeners through the whole journey again. But just to like preface, like, when you first told me about Droplet, I was like blown away. Like, and I still am, you know, like, to this day, I'm like, this is so revolutionary, especially now, I think more than ever, when consumers care so much about like, are you getting the most out of your products? Is it going to the layers it needs to go into? So all of that stuff coming together and like understanding your science is so, I don't know, it's just such a fresh, like a breath of fresh air, you know, in the industry.
1:09Dr. Ekta Yadav:So with me ranting, I want to now give you the mic and have you tell us, you know, tell us about Droplet for everybody that might have missed the first episode. You know, where did it start?
1:20Madhavi Gavini:So Droplet initially started as a medical technology. So my background is in pharmaceutical development. I worked in designing drugs for pediatric patients. And along the way, I worked in pediatric cardiomyopathy, so heart disease in children. And along the way, I learned about this rare disease called epidermolysis villosa, which anyone in the dermatology field is unfortunately very familiar with. And it's basically one where patients are missing a gene that codes for a connective protein that connects your skin to the tissue below it. and when that gene is missing, the skin doesn't properly adhere.
1:57Madhavi Gavini:So as a drug designer, the way I've been trained to think about it is you target the protein, like you, you find a therapeutic and then, you know, you're, you're done. The disease is cured. And unfortunately for skin, for many skin conditions, that's just not true because delivery is actually the big challenge. So in this case, the treatment is a gene therapy, which is, you know, like not to minimize the field, but it's doable, right? But the issue in terms of actual treatment is getting the gene to where it needs to go in the tissue. So that's how I got involved in the delivery problem. And that was the entire basis for droplet technology.
2:31Madhavi Gavini:So what we've designed is this little handheld device that's able to take very large molecular weight ingredients, molecules, things like genes, but also things in the cosmetic space, like collagen, like exosomes, and we can deliver it painlessly into your skin by basically creating these very fast moving submicron droplets that can penetrate the stratum corneum and you get effective delivery. And that's kind of the core technology. We are a little bit bifurcated, right? We have a whole arm of the business in the medical side where we work with partners at Tufts Medical Center. We've worked with collaborators at MIT and a few other universities, including Walter Reed and the University of Columbia, doing delivery of things like gene therapy.
3:16Madhavi Gavini:We'll talk a little bit about exosomes. So we've done a lot of work with that more recently, and then also antibiotics. And then of course, taking that same core technology and applying it to skincare where you have exactly the same issue, which is there are amazing ingredients out there, but we're not able to unlock their potential until they actually get into the skin. And now we have a way of doing that.
3:36Dr. Ekta Yadav:Yeah. No, it's so, so fascinating that you started from that space, you know, because I mean, I have these conversations on this podcast and I feel like no one ever talks about how like some of the most crazy good innovations come from this like really deep understanding of just like health and like genetics and cellular, you know, biology and all of these things that we don't really get to hear much about, you know, as in the consumer space. And so I love that droplets origins are from that like very, very heavy science, because I think that's what this industry needs more of. And so I want to kind of like play on that and have you really talk us through exosomes because I'm sure you've seen it.
4:09Dr. Ekta Yadav:We've all seen it. Exosomes are everywhere. Everything's buzzing about them, you know, and I really feel like the information is just not complete, you know, with the science and the knowledge. So I'd love for you to explain exosomes to us and just kind of like walk us through it like a one-on-one.
4:23Madhavi Gavini:Yeah, of course. Okay. So exosomes are extracellular vesicles that are secreted by cells. So they're secreted by both healthy cells as well as sick cells. And basically the envelope, the thing that makes the external shape of the exosomes is able to be readily, can be readily absorbed by other cells. So they're basically these cell to cell messengers and they contain many, many things inside of them. You know, exosome characterization is kind of its own field, but at a high level, it contains DNA, RNA, multiple types of RNA, so messenger RNA, siRNA, and so on. And then it also contains various proteins and they are kind of this active area of research because there's been some very interesting observations in the field where essentially if you take the exosomes from cells that have, um, that are sick, right?
5:17Madhavi Gavini:So cells like hypertrophic cardiomyocytes, for example, and you put them next near healthy cells and they get absorbed, those healthy cells take on that same profile. They become sicker. And the inverse, which is why it's relevant to medicine is also true. If you take exosomes from, let's say healthy mesenchymal stem cells, and you apply them to injury. So to, you know, injured or insulted skin or tissue or organs, you get really interesting recovery. And so it was really this observation that, you know, blew up the world of exosomes. And I think we're still trying to understand as a field, you know, the true potential, like what can they do?
5:58Madhavi Gavini:Where are in fact the limitations? And, um, there's a whole area of research as well in creating synthetic ones, which as far as I'm aware, it's, it's not quite, it's not the same as, as, you know, what's biologically like what's derived. And then as with many things, there's hype around it. So, um, now there's talk about like plant exosomes or exosomes coming from non-human sources being applied to human biology. And it's just not the same.
6:25Dr. Ekta Yadav:It's not the same. Yeah. No, I'm glad you touched on that. And I actually want to ask you a follow up on that because I think regenerative medicine is taking off, and I see it applied every day more and more in skincare. But I think there's a huge misunderstanding also that's taking place where people are now saying stem cells and exosomes in the same sentence, and they're confusing the two. So I want you to explain that to us too, if you can. What is the difference between a stem cell and then the exosome itself? Of course.
6:51Madhavi Gavini:Well, a stem cell is a cell. They are typically like pluripotent or multipotent, which means they have the ability to differentiate into a bunch of different tissue types, right? They can become theoretically skin cells or they can become cardiac cells or brain cells. And they're a very interesting source of exosomes, but you can't deliver, there isn't at the moment a universal stem cell that you can deliver. so you can do what's called autologous stem cell transfer. It's used therapeutically in quite a few different indications, including cancer treatment, I believe. But the idea there is you're taking your own stem cells and then you're administering it back to yourself.
7:30Madhavi Gavini:And that's fine because you're not going to have an immune response to it, but you can't take, let's say my stem cells and administer them to you because there's going to be an immune response. It's not necessarily compatible. And it's an extreme example of that would be like organ rejection. Like you need, you need a match. So there are companies working on universal stem cells that don't trigger an immunogenic response, um, or an allergenic response between, you know, between people that can be used across the board. And I think that's very exciting research, but it's not, it's just not commercially available yet.
8:00Madhavi Gavini:So, um, so stem cells like are not, you can't use those at the moment, um, unless they're your own, but exosomes are secreted by stem cells and they contain a large amount of like the goodies in stem cells, right? They are the signal to cells to proliferate, to regenerate and, you know, and to basically behave like younger cells for lack of a better phrase. And so you get much of the same benefits in some of the more current research from the exudate of those stem cells. So that would be what we call the conditioned media. And that contains obviously exosomes, but other things too. And that's often what's used in regenerative medicine.
8:40Madhavi Gavini:So it's coming from stem cells, but it's not the cells directly.
8:43Dr. Ekta Yadav:Makes sense. Yeah, it makes a lot of sense. And also, I like that you brought up plant exosomes. Yeah, we've talked about that a few times. So Madhuri, I want to ask you about exosome, like the actual sourcing, because not all exosomes are created equal, as we have seen. I think a lot of times, like, you know, the industry can kind of put the cart before the horse. And so I think that's happened with exosomes. And it's really important for us to understand like, what do we need to know about the sourcing and then cell quality and all of those things, if you could kind of tell us about that.
9:14Madhavi Gavini:Right. So the way we think about it at Droplet is exosomes in a way are a proxy for the quality of the cells and the type of cells that you're administering. So for example, with the product that we're launching, our exosome starter set, we source our exosomes from mesenchymal stem cell conditioned media. And what that is, is they're mesenchymal stem cells. So they are human derived from like healthy consenting adult donors who are, who are young and screened. And we basically work with the biotech company. They basically grow these cells to confluency and they extract the conditioned media. And that media is a source of our exosomes.
9:54Madhavi Gavini:So those cells are healthy. Like They are viability checked. They are nice and round and happy cells. And so the quality of the exosomes as a result of that are quite good. In contrast, if you were to source exosomes from, let's say, like cardiomyocytes, heart cells, they're probably not going to do much for your skin because it's a completely different cell type. You might see some benefit, but it's unlikely that you'll see a lot of regenerative potential unless you're administering them to the cardiac tissue. And similarly, if you are growing cells under like suboptimal conditions and those cells aren't happy, then the exosomes, and I actually heard about this happening, like people are using immortalized cell lines, which are cancer cell lines.
10:39Madhavi Gavini:You're getting exosomes from that. Like you should not be administering those to people, right? Those are sick, cancerous cells. So the source of the exosome is really, really critical in terms of the constituents and the quality of the exosome.
10:53Dr. Ekta Yadav:That makes sense. And it's important to understand that, I think, because people are throwing around the idea that this is regenerative, right? So regenerative medicine, what does that mean? So it's going to help heal your skin. And so if you're not getting the right signals that are going to be mimetic with those cells, you're not going to be able to elicit that cascade that's going to lead to regeneration. And I think that's, I mean, a lot of times I think consumers get lost in that, you know, because we think exosomes and exosomes stem cells, a stem cell, why does it matter? But I think that's a very, very important differentiation.
11:25Dr. Ekta Yadav:Now, talking about mesenchymal stem cells, I would love for you to dive deeper into this, you know, like go deeper into like why that matters in terms of deriving exosomes from these specific stem cells, especially when it comes to regeneration.
11:38Madhavi Gavini:It's a good question. So mesenchymal stem cells are a pluripotent stem cell line, which means they have the ability to differentiate into multiple different tissue types. And so as a consequence, the exosomes that they secrete contain a very broad array of signaling molecules, and those are designed to act across a broad array of tissue types. And that's really like the key for why we find this, we find this so interesting. And there's a huge amount of academic literature on mesenchymal stem cell condition media and mesenchymal stem cell exosomes. And in fact, in our own work, We partner with a group at Tufts Medical Center, Dr.
12:16Madhavi Gavini:Lakshmi Polakad, and the work we do with them is supported by the DOD. We recently, you know, this is not quite yet published, but will be soon. But one of the projects we did with their Technology and Therapeutic Development Award was delivering exosomes for mesenchymal stem cell condition media through droplet into what are called stage four pressure ulcers. and these are chronic non-healing wounds. You're familiar with them, obviously, with your background. So as you know, the tissue and muscle regeneration in stage four ulcers, and these were in murine models, those are not recoverable with any current technology.
12:55Madhavi Gavini:What we've been able to demonstrate is using the exosomes from this conditioned media, which is the same thing that we are launching in our cosmetic product. We're actually able to see recovery of that tissue. So you're able to get muscle covering up those ulcers and those wounds are healing and you're recovering some function for the limb. And that for us was like the most compelling piece of evidence that made us very excited to continue working with this particular product. And yeah, I think that's really like what gets us excited in the morning.
13:26Dr. Ekta Yadav:That's amazing. I'm over here just like cheesing because I'm like so excited for you. That's phenomenal. That's phenomenal. And so you haven't published it yet, right? Because I want to link
13:35Madhavi Gavini:get for our listeners to know we have a few other papers that we're happy to happy to link and this one's um this one's coming out soon but where it's obviously with with our collaborating partners and that's going to come out um fairly soon we hope well that's oh my gosh that's amazing and for everyone listening out there i mean if you guys could see like if you see these wounds and like
13:54Dr. Ekta Yadav:just how much of a brick wall you run into when it comes to anything related to healing them any anything i mean it's like it's like a climbing a mountain you know so that is absolutely phenomenal I'm so excited for you. And I'm so excited for everybody to try this product because of that, because if you can elicit anything that is, you know, healing in nature and something like that, where your body is literally screaming for help, and it's pretty much run out of all of its supply of trying to heal itself, that's huge. You know, it's a huge statement. So with that in mind, I want to move on to understanding exosomes a little bit better because, you know, I think one of the biggest things that comes up, right, is that a lot of times the preparations of these exosome products lead to them actually becoming, you know, just kind of inert.
14:41Dr. Ekta Yadav:You know, there's nothing really left there because they're incredibly fragile. So, you know, can you talk us, Mohamed, through that? Like, why is there so much difficulty in using exosomes in skincare, and how does fragility really play a role in making sure that the products are really viable when you get them?
14:58Madhavi Gavini:Sure. No, it's a good question. So exosomes are, so exosomal storage, you're going to inevitably get some degradation in the way it's stored once you extract it from, right, from a tissue source. And typically like in a medical setting, and that's what we replicate in a lot of ways at Droplet, you would take this and you would keep it frozen. Like this is not a product that can be stored at room temperature when it's in a solution. And so that's actually what we do. So with our product, we get it from the manufacturer on ice. It's formulated on ice. We've built these fill seal robots that temporarily thawed and fill it.
15:37Madhavi Gavini:And they're extremely fast. They're like hundreds of times faster than a person would be. And they're in single dose capsules that are stored in your freezer that we ship them to you on ice. So we kind of do that end-to-end cold storage. And we've sort of verified it, or we've had it shipped to a customer and ship back and confirm that there is like bioavailable products still in there. Unfortunately, like exosomes are not particularly stable at room temperature. So they might be for a couple of weeks, but if you think about the life cycle of most products, they're, you know, they're just not, you're not even getting to them within the first few weeks of those, of that product being made.
16:10Madhavi Gavini:And then when you think about storage, so if you're not freezing it, then there's a process called lyophilization. And that's basically where you're, you're drying it out. And so you are able to preserve stable exosomes that way, but the problem isn't the lyophilization, it's the rehydration process. So when it goes back into solution, especially if you have emollients or other products, it's going to degrade the outside, right? That lipid layer. And then the constituents of it will get secreted and degraded. And as a result of that, you know, you and I have talked about this before, like when you do SEM, you don't really see exosomes in the majority of in any of the products really yeah hexazones exactly yeah no exactly I mean that's
16:51Dr. Ekta Yadav:that's really interesting though that it's that re-thawing process you know what I mean and that's the interesting part because I think people just think like these are little vesicles and they're just going to stay that way but it's yeah I mean they're little like little membranes just you know just closed on themselves I mean that's a huge huge thing and I I really feel like the industry like needs to educate on this and for anyone out there that's like using an hexazone product like I really urge you to ask your brands, how did you make this product? And I'm not trying to call anybody out. I'm just being honest.
17:21Dr. Ekta Yadav:From the science perspective, it's worth understanding these details because that's the viability of the product. I want to talk about, though, this whole degrading at room temperature thing. How long can something stay viable at room temperature? I mean, just to give people a little framework.
17:40Madhavi Gavini:Well, it depends on the format. So if you have something that's like in an emollient, it's a very short period of time because that fat is degrading the hydrophobic layer essentially, right? So that's pretty limited. If it's in like a saline-based solution with a preservative system, probably a few weeks, that's about your max, maybe a month. But even then, it's continual degradation, right? So you're talking at like 100 % down to 0 % is kind of that time course.
18:08Dr. Ekta Yadav:Makes sense. now in terms of like okay so being intact is huge you know that's like the big thing you want to make sure your product is actually usable but then obviously like in the u.s you know like we can't inject exosomes like even in a clinic it's not allowed by the fda so like why does delivery really matter here and like like i would love for you to speak on this um in terms of like you know getting that potential out of these products you know in terms of like the delivery component?
18:34Madhavi Gavini:Well, so exosomes, so your skin is a barrier, right? Like fundamental skin biology, your skin is a barrier, protects you. And so it's designed to keep things out. And exosomes are quite large molecules. So the rule of thumb is anything over 500 Daltons, and a Dalton is a unit of molecular weight, anything over 500 Daltons can't penetrate. And there's obviously exceptions, like heparin is a famous example of an exception to that. And there are things under 500 Daltons similarly that don't get in. So that's, it's just a general rule. Exosomes are thousands of times larger than 500 Daltons. They are very, very large vesicles.
19:10Madhavi Gavini:And so you do get, I think a little bit of a tiny bit of absorption when it's applied topically, but it's, it's very little. So there's no, it's not enough to really have a proper biological effect. And that's where the droplet technology comes in because once again, our core technology is taking these very large things and delivering them past the stratum cornea where they can get into your skin. And so when you pair the two of them together, as we did in that stage four pressure ulcer murine model and some of our other published data, you're able to achieve painless delivery and that ingredient remains stable and can be biologically active, resulting in the benefit.
Read the full transcript
19:52Madhavi Gavini:That makes sense.
19:53Dr. Ekta Yadav:Yeah. I mean, I think that's a big thing for regenerative medicine right now. I think in general, because people are piling on all of these products and they're just like, well, it's going to repair my skin. And it's like, well, that's if it gets to the cells it's supposed to get to, you know, like, especially when you're talking about, I mean, you know, there's so much buzz around like fibroblast signaling, you know, protecting keratinus, all of this stuff, but it's like, you're not even reaching that area. You know what I mean? So like, that's where I really worry about consumers because they end up spending so much money, you know, and on a lot of these products and then don't get any results.
20:25Dr. Ekta Yadav:So that's right. Right.
20:26Madhavi Gavini:No, no. And in a clinical setting, because that's one place where they are used. And also it's interesting because if you talk to any germs who use it, it's always frozen. So this is clearly something people in the field know. But they typically do it after microneedling. So you are insulting the skin, right? You have basically like holes being poked into your face. And so you have some improved permeability for that period. And I think that's very interesting. However, we do know that like continuous repeat application of this is, is the most beneficial. So you, you get benefit from once or twice, but it's a little bit more, I mean, this is a silly analogy, but it's a little bit more like a vitamin.
21:07Madhavi Gavini:Like you want to be taking that every day to keep those circulating levels higher. And so you can't, you shouldn't micro needle your face, medical micro needle your face every day. And I think that's, that's where this technology and the ability to do it at home, um, like unlocks that additional dimension and the potential of this product.
21:23Dr. Ekta Yadav:Absolutely. Yeah, absolutely. And also because so many people are scared of microneedling too. I've heard that a lot. A lot of people will chime into our emails and be like, I don't want to do microneedling. What can I do? And so this is amazing, amazing for all of you out there that are just too scared or maybe just didn't sit well with you. This is a really great option as well. So I know you guys have a professional arm to all of this. If you could tell us more about that versus the one that's going out to consumers.
21:49Madhavi Gavini:Yeah, absolutely. So we have an exosome product called Trillium, and that's what we use in dermatology clinics. So we have various professionals who are using it across like New York and Boston. And that is a pure exosome product with just a minimal preservative system. So, you know, purely derived from human stem cell condition media. It's a high concentration, obviously, it's like 100 % essentially, and we use that same core ingredient as a basis for our exosome capsules that are sold to consumers. So think of it as like the professional strength and the at-home strength. And that version is used in a couple of ways.
22:28Madhavi Gavini:They use it after microneedling, but it's also being used after laser treatments. And that one's actually pretty interesting. So if you're familiar with laser, you know that they do ice packs after and ice packs are obviously great for cooling the skin, but you can sometimes like vasoconstrict a little bit too much and it can impair healing. And the mechanism of these is anti-inflammatory. So you're kind of turning off like those inflammatory signals and turning on like regenerative ones. So you get the same like sensation of cooling, but without the risk of vasoconstriction. And so we've had quite a few practices who use it now in lieu of ice packs and they've seen improved healing in their patients after laser treatments.
23:09Dr. Ekta Yadav:That's really interesting. So basically, this is an in-office. This is the in-office version. So that's really, really fascinating. I mean, I think that for me, I don't understand. I know a lot of people use the ice baths. And that was exactly... I used to always wonder that. From a science perspective, it's like all that vasoconstriction, like you're not getting blood to where it needs to heal. So that's really interesting. And then in terms of like understanding. So I know like since the professional arm is there and then you can go into an office like, you know, Dr. Belkin's office, you can go there and get that done.
23:42Dr. Ekta Yadav:So then do you follow up with at home maintenance with the consumer product at home then?
23:47Madhavi Gavini:Yeah. Yeah. That's exactly the way to think about it. And I think there are kind of two different things. One is like a big bolus treatment after, you know, insult or injury to the skin and tissue, whether it's microneedling or laser or whatever. So the idea there is improved recovery and regeneration after that injury. And then the at home is just kind of keeping the stable, elevated, like steady increase. It's almost like your daily vitamin in that sense. And so yeah, the benefits are different. One is like acute and the other is more longitudinal.
24:14Dr. Ekta Yadav:Makes sense. Makes sense. That's really exciting. And I'm glad that you did that because then it's like, you know, you have a full like treatment that you're following through on. And I think, especially, you know, I wanted to say this and I, and this is my opinion, you know, So for everyone listening, like, I feel like that when you can stick to a routine, like, when you have an easy way to stick to it, like, you're going to see the results. And I feel like especially with these, like, emerging fields of science coming into skincare and topical delivery of these ingredients, I mean, it's so, so important, I think, now more than ever for people to get on a routine.
24:45Dr. Ekta Yadav:And I feel like Droplet just, like, I don't know. when I first, like I said, when I first discovered you guys, I think that's why I was just so obsessed because it was like, this is something you can use every day and you don't have to think about it. It's like everything's built in, right? Like the consumer experience and like, you know, you use the device, you know, it's getting done, you know, the ingredients are going where they need to go. And so I just feel like it's so great for those of you out there that are like, I don't know what to do with my routine. I'm too lazy or I'm too tired at the end of the day, you know, those kind of factors, this eliminates a lot of that, you know?
25:19Dr. Ekta Yadav:And so that consistency is going to be built into using a device like this. So I just want to say that for our listeners, because so many people, Madhu, honestly, I can't tell you, so many people chime in with like, I don't know how many steps I should be using at night and all this stuff, you know? And so it's so important to have these kind of options in the industry. But yeah, no, I mean, you know, huge hats off to you. I mean, honestly, this is such a breakthrough and I can't wait for people to discover the exosome product. I've been using it myself. I love it. And I'm just so excited for you to bring this.
25:51That's great.
25:52Madhavi Gavini:No, no, we are too. And love getting the technical questions. I think we're happy to talk science all day. So it makes us so happy when other people are equally willing to geek out with us on it.
26:02Dr. Ekta Yadav:So excited to welcome back Dr. Dan Balkin, who is a double board certified New York City based dermatologist. Dr. Balkin was on the show, if you guys remember a few episodes back, talking to us and educating us about lasers. And today he is going to tell us about his use of droplets exosomes, professional products in his practice. Welcome back, Dr. Belkin. I'm so excited to have you back. Hi, Dr. Belkin. Welcome. Good to see you. Yeah, good to see you as well. I'm excited you're joining us. I have a few questions for you. I wanted to, we were just talking about Droplet, you know, in terms of like, like really kind of the logistics and understanding like how to use the device and like what it means.
26:38Dr. Ekta Yadav:And I think from your perspective, I'd love to learn more about in the professional setting the real benefits of using the device and especially with the exosome product. Can you tell us how are exosomes being used in professional applications right now in dermatology? Well, exosomes are still being, they're sort of like the frontier of sort of regenerative skincare and medicine. And I think they're still being studied and they're very exciting. And there's a lot of anecdotal evidence that they're helping with skin aging and hair growth. And a lot of people all over the world are injecting them dermally or subdermally, but that's not legal to do in the United States.
27:22Dr. Ekta Yadav:They're not FDA approved for injection. So the way that people get around that is they're using it with either microneedling. So with microneedling, you can get penetration through the stratum corneum and you'll get higher concentrations into the epidermis and the dermis. or with the Droplet device. So when one of my patients first told me about Droplet and I connected with the company, I was really skeptical because I was like, to get dermal penetration of topical ingredients without needling seems kind of unbelievable. And so I was really skeptical of it, but excited. And then when I met with them and I talked to Madhavi, she showed me all the research and it's kind of amazing.
28:08Dr. Ekta Yadav:So it allows me to get thermal penetration of actives without any injury to the skin. Yeah, that's, I mean, it's really remarkable. And I'm just curious, what has your experience been historically with exosomes? Like in terms of like maybe even results or just maybe some hiccups that you've kind of encountered using them in the office? Well, I haven't really been using them because I haven't really felt comfortable doing that with exosomes. They're human-derived. And a lot of the topical products are kind of unclear. The sourcing is unclear. Sometimes they don't have good cold storage logistics.
28:48Dr. Ekta Yadav:There's no cold. So you don't know if it's being refrigerated the whole way. Sometimes they're plant-based exosomes, which really don't do much at all. And so you just don't really know what you're getting because it's not FDA-approved. There's just not a lot of regulation. So Modivi will go into it more, But Droplet sources its exosomes from the same place as the Department of Defense. There's cold storage logistics. I feel very comfortable with where they're sourcing. And so this is sort of the first time that I've started incorporating exosomes into the office. I haven't been doing it before.
29:21Dr. Ekta Yadav:That's interesting. Yeah, I mean, I feel like this is a whole new category in itself. I mean, what Droplet's doing and the way you guys are reintroducing. I mean, I feel like I was talking to Madhuri about this, Dr. Balkan. And I don't know if you agree, but it was like we put the cart before the horse with some of these regenerative medicine ingredients, I feel like. Absolutely. Now we're circling back and we're realizing that was never going to work. So this is really, really fascinating and incredibly exciting to see that you can obviously go into an office and have a professional do this for you or you can do it at home.
29:54Dr. Ekta Yadav:And so I just want to get your take on that as well, you know, in terms of putting this into the hands of the consumer, giving them the ability to really interact with regenerative medicine. I mean, what are your thoughts around that? I mean, I think it's great. Like, I think people want to have something that they can do at home. I think that obviously we have to feel comfortable that what we're putting out is safe. But I think, you know, people want to do something at home. They want to be active in, you know, in doing something that's beneficial for themselves and their skin. And I think, unfortunately, there's so much, you know, there's so many devices that are marketed to consumers that really don't work and really don't have good evidence behind them.
30:37Dr. Ekta Yadav:And, you know, I think it's great that Droplet is not super expensive. It's high quality ingredients. It has real R &D behind it. you know, I really like it. You know, I get so many devices sent to me and I hear and I have so many people talking to me about their products, either like their skincare products or their devices. And it's like, you know, the data is just never really that robust. Yeah, no, I agree with you. I think this is and that's why I asked you was to kind of put our listeners, you know, mind at ease a little bit because this is so, so amazing. And I think it's such a breakthrough.
31:11Dr. Ekta Yadav:And, you know, at the end of the day, like I get so many emails, I was telling Maudry about this, Like I get so many emails from people that are like, well, where do I layer this? And I want to buy like five different products that are regenerative medicine focused. And it's like, you guys, you know, like it's about delivery. It's about, you know, getting it to where it needs to go. And then is it going to even act on yourselves? Is it going to totally. So, yeah, I mean, I think that's the fundamental. So, you know, it's incredibly important for all of our listeners out there to understand, like the impact this device has in this industry at this time in this format, you know, so.
31:45Dr. Ekta Yadav:So that's huge. It's huge. Like for better or for worse, you know, the FDA doesn't monitor skin care, you know? So it's like you can, there's all of these claims that, or that can only be regulated on sort of a post-market basis, not pre-market. So you don't know, like something can say 20 % vitamin C, but it could totally denature on the shelf in a day. Or if it doesn't, it could just sit on the surface of your skin and not penetrate at all. Like there's, you know, you can make so many claims in skincare that you don't have to back up. And so, you know, so I think consumers will rely on dermatologists, beauty editors, you, scientists, you know, there's all of these other ways that you can sort of make sure something is legitimate.
32:30Dr. Ekta Yadav:But it's a hard area for people to really know what's real. Right. Now, in terms of post-procedure care, how do you feel that this fits into post-procedure care? Because I think a lot of people are getting like, you know, obviously like the microneedling, that's what we've been hearing most about is like microneedling and then you do the exosome treatment. But then if you do get just normal microneedling, how do you feel that the droplet device fits into that kind of post-procedure recovery? I think it'll be great. I mean, I'm just sort of like rolling it out now. But I think, you know, so far what I've seen is that, you know, it's immediately soothing.
33:06Dr. Ekta Yadav:The exosomes, like any sort of collagen stimulator or peptides, should help with healing post-laser and anti-inflammatory benefit post-laser. So it sort of allows us to kind of combine multiple treatments. So you could do like microneedling with radiofrequency, and then you can do the exosome treatment with droplets. So you're getting both the benefit of the radiofrequency, the microneedling, and the exosomes in one treatment. That's awesome. I love that. Well, thank you so much, Dr. Balkin. This was very helpful. Yeah, good to talk to you again, Ekta. I'll talk to you another time. Likewise. Yeah.
33:43Dr. Ekta Yadav:Thank you so much. Yeah. You know, I want to dive into the actual product, though. I mean, it's so cool what people are getting. I mean, why did you decide to make the starter set with the ExoZone product with Droplet, the actual device as a starter set?
33:56Madhavi Gavini:Well, okay. So we launched the product. we launched the serum treatment like in our capsules a while ago, like a couple, like, you know, and, and we, we did it because we were very, like, we were very interested in the science and we're like, I think people want this. Let's see what happens. And then it became one of our most popular products. And, you know, we've had like over 300 ,000 treatments and it's like our stickiest SKU and people really love it. And we were like, we should make this like an introductory price, like an introductory product into our portfolio. So we made it, we basically made it a formal starter set.
34:30Madhavi Gavini:And that's something that we're really excited to be launching. And we think that there are so many, I think people are so much more sophisticated about skincare and ingredients than they were pre-COVID because everyone just got bachelor's in biology during that time period, essentially. And the types of questions we get from customers, they're so smart. And we've just wanted to be like, here's the product that you were clearly looking for. Just get the set. You are good to go. You're going to love it.
35:03Dr. Ekta Yadav:Yeah. I love that you did that though. I mean, that's like, it makes it a lot easier. And I agree. I think, because it's exciting to hear about these technologies, but then how do you use them? That's a huge question. So I mean, this is like kind of a one and done and you know exactly what to do and like how to use it. But you mentioned the capsules. Can you talk to us about what exactly are the capsules and walk us through like, oh, what's inside of them? And And why did you go to such great lengths to really keep them cold?
35:29Madhavi Gavini:So, okay. So we take mesenchymal stem cell condition media. That's like the primary constituent of these. So just to briefly describe it, the way we set up our system is you buy the droplet delivery device, right? It's a microinfuser. It works with all of our products. And then with this particular set, we also give you a month's supply of our exosome serum. and so they're packaged in these capsules so they're single use think of it like a curiger and espresso so you pop it in and turn it on and um the the beauty of it is it the majority of it is kept in the freezer except for the one unit that you're using at that given time so you are able to preserve stability you're getting consistency of dose so the same amount in your skin every time that's like the pharma background coming in because we care about dose consistency and it is designed basically so that for daily use so we recommend using it in the evening.
36:23Madhavi Gavini:Although we certainly have people who use it in the morning. We have people who use it twice a day. It's kind of up to you in a lot of ways. So yeah, so that's kind of how the system, how the kit is set up. And then we have it on subscription as well. So you can get it as a single purchase or you can buy it on subscription.
36:38Dr. Ekta Yadav:I love that. So it's easy to kind of keep track of when to use it, how frequently to use it. I think that's really, really important too, because I know we get a lot of questions about these kind of ingredients and like, Like, well, when should I be integrating this into my routine? You know, and like where and like, you know, what layer is it supposed to be in? So that's really good to know. And how would you pair it with all of the other options?
37:00Madhavi Gavini:I would use this first. So use it on clean skin, like after you've washed your face. And it's the first product you use. And that would be true for other products as well. So, you know, first thing that goes on your face, then you can do your regular routine if you wish on top of it. And it should not interfere in any way with that. So I'd say that's probably the most common way in which it's used.
37:20Dr. Ekta Yadav:That's awesome. I love that. And you know, because with exosomes, like you want to get them on your skin first, right? Like I'm understanding that like you want to let them do the signaling and do all the stuff they're supposed to do.
37:29Madhavi Gavini:Yeah. And I think it's a little bit of a flip from the convention that you put the smallest ingredient on first. Yeah. In this case, it's yeah. In this case, no, this is, this is definitely the first thing you should be using.
37:40Dr. Ekta Yadav:That's really, yeah, that's really good to know. And so what if somebody is, so if somebody is using, and this is, I think my general, I have a question in general about the droplet system is like if people are using like, you know, cause everyone loves like milky toners these days, they love like layering other things like a mist or something. Can, is it still safe to go in then with the droplet device and still do this? Or do you want this to be like on completely bare skin?
38:02Madhavi Gavini:You're going to get the most benefit when it's on totally bare skin. We do have people who will do it on top of other products and you should still like, you'll still get penetration and benefits. But I think like the optimal case is definitely on clean dry skin.
38:16Dr. Ekta Yadav:So I want to actually talk a little bit more about like, you know, in terms of like the delivery, like, because I mean, clearly this is going a lot deeper, right? Than just applying something topically. We've kind of established that now. But what do you want consumers to understand about like how deep we're getting the product and the actual ingredients and like what that means for like overall skin's ability to utilize the, you know, the exosomes and actually start that signaling?
38:42Madhavi Gavini:Right. Right. Well, I think this is an analogy I've used a few times when we've been like actively fundraising for the business, but if you have a headache, you're not going to put an aspirin in your pocket. You're going to swallow it. And it's kind of the same thing here. Like if you have a skin problem you're trying to treat, you want it to actually achieve, like hit those skin cells. Otherwise you're not going to get that mechanistic improvement. And so if you think about the skin, you have the stratum corneum, which is like that outer layer, and you need things to get past that. And anything that gets past the stratum corneum is going to diffuse.
39:11Madhavi Gavini:So it's going to go into the epidermis and dermal layers, and you're going to get a biological function. But really, it's just getting past that stratum corneum barrier. That's kind of key. Yeah.
39:19Dr. Ekta Yadav:And I mean, I think that's why I asked because people are always like, well, where do these act? Where do exomes actually act? And so that makes a lot of sense. Now, I know we have a code for our listeners. So if they want to use the code, what is the code? So the code is anarchy, as in skincare anarchy. That's amazing. Thank you so much for the code. And I hope everyone listening, scroll down in the show notes and you'll see it right there as well. We will also be popping everything in our stories to make sure you guys are checking that out. But Madhuri, thank you so much. This was amazing learning from you.
39:47Dr. Ekta Yadav:Thank you so much for having me. Yeah, no, I'm just, I'm so excited that you're bringing this forward. And we need it, you know, as an industry, we need something like this. So very cool.
39:54Madhavi Gavini:Thank you so much. No, we're excited too.
From the publisher
In this special episode of Skin Anarchy, Dr. Ekta Yadav welcomes back Madhavi Gavini, founder of Droplette—one of the earliest science-forward brands featured on the show. What once felt like a radically different approach to skincare technology now feels increasingly relevant as the industry shifts toward biologics, regenerative ingredients, and delivery science. The conversation revisits Droplette’s origins and explores why effective delivery may be the missing piece in modern skincare innovation.
Gavini’s journey into skincare began far outside the beauty industry. With a background in pharmaceutical development, she spent years designing therapies for pediatric diseases, where she encountered one of medicine’s most persistent challenges: delivery. Even when researchers identify the therapeutic molecule that could help treat a condition, getting that molecule into the correct layer of skin is often the hardest part. That realization became the foundation of Droplette’s technology, originally developed alongside MIT-affiliated researchers to enable large molecules to reach skin tissue without needles or barrier injury.
The Droplette device generates high-velocity, submicron droplets capable of moving ingredients past the stratum corneum—the skin’s protective outer barrier—allowing molecules far larger than traditional topical ingredients to access viable layers of skin. The implications extend beyond cosmetics, with ongoing collaborations exploring delivery for antibiotics, gene therapies, and other advanced biologics.
The episode also dives into the science behind exosomes—one of the most talked-about yet misunderstood areas in regenerative skincare. Gavini explains what exosomes are, why sourcing and stability matter, and why many topical exosome products degrade or fail to penetrate the skin barrier. Double Board-Certified Dermatologist, Dr. Dan Belkin, also shares his clinical perspective on how exosomes are currently used in dermatology and why reliable sourcing, cold-chain handling, and effective delivery systems are essential for maintaining biological activity.
Listen to the full episode to hear Madhavi Gavini explain how Droplette is bringing pharmaceutical-grade delivery science into the future of regenerative skincare.
Use discount code 'ANARCHY' to get the Exosome Starter Set on subscription for just $349
1.Quek BL, Srinivas RL, Gavini MP. Droplette: a platform technology to directly deliver nucleic acid therapeutics and other molecules into cells and deep into tissue without transfection reagents. Methods Mol Biol. 2022;2398:211-230. doi:10.1007/978-1-0716-1811-0_14.
2.Mahmood A, et al. Droplette—a fluid dynamics-driven platform for transdermal and intracellular delivery of large molecules. FASEB J. 2018;31(S1):924.7.
3.Pulakat L, Chen HH, Gavini MP, Ling LA, Tang Y, Mehm A, et al. Transdermal delivery of high molecular weight antibiotics to deep tissue infections via Droplette Micromist Technology Device (DMTD). Pharmaceutics. 2022;14(6):1134
*This is a sponsored collaboration




